Hot Pursuit     03-Oct-22
Zydus Lifesciences Ltd soars 5.17%, gains for fifth straight session
Zydus Lifesciences Ltd is quoting at Rs 406.9, up 5.17% on the day as on 12:44 IST on the NSE. The stock is down 27.62% in last one year as compared to a 3.91% slide in NIFTY and a 10.71% slide in the Nifty Metal.

Zydus Lifesciences Ltd is up for a fifth straight session today. The stock is quoting at Rs 406.9, up 5.17% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is down around 0.55% on the day, quoting at 17000.35. The Sensex is at 57090.81, down 0.59%. Zydus Lifesciences Ltd has gained around 9.62% in last one month.

Meanwhile, Nifty Metal index of which Zydus Lifesciences Ltd is a constituent, has gained around 5.26% in last one month and is currently quoting at 12971.9, up 1.96% on the day. The volume in the stock stood at 41.41 lakh shares today, compared to the daily average of 12.22 lakh shares in last one month.

The benchmark October futures contract for the stock is quoting at Rs 411, up 5.64% on the day. Zydus Lifesciences Ltd is down 27.62% in last one year as compared to a 3.91% slide in NIFTY and a 10.71% slide in the Nifty Metal index.

The PE of the stock is 37.95 based on TTM earnings ending June 22.

Previous News
  Zydus Lifesciences consolidated net profit rises 298.62% in the March 2024 quarter
 ( Results - Announcements 17-May-24   16:25 )
  Zydus Lifesciences Ltd Slides 1.88%
 ( Hot Pursuit - 18-Jun-24   09:30 )
  Zydus receives USFDA tentative approval for Edaravone Injection
 ( Corporate News - 14-Mar-24   13:51 )
  Zydus Lifesciences appoints director
 ( Corporate News - 17-May-24   15:47 )
  Zydus Lifesciences to hold AGM
 ( Corporate News - 17-May-24   17:45 )
  Zydus Life gets tentative USFDA approval for Letermovir tablets
 ( Hot Pursuit - 23-Mar-24   14:21 )
  Zydus Life gains after receiving USFDA nod for Chlorpromazine Hydrochloride Injection
 ( Hot Pursuit - 14-Mar-24   13:05 )
  Zydus Lifesciences receives USFDA approval for Isosorbide Mononitrate ER Tablets
 ( Corporate News - 16-Feb-24   14:31 )
  Zydus Lifesciences Ltd spurts 1.16%, rises for third straight session
 ( Hot Pursuit - 26-Feb-24   13:05 )
  Zydus Lifesciences launches oncology drug - Rexigo™
 ( Corporate News - 30-Jan-24   09:49 )
  Zydus Life rises after receiving EIR report for Ahmedabad-based facility from US FDA
 ( Hot Pursuit - 13-Sep-23   13:47 )
Other Stories
  RVNL gains on emerging as L-1 bidder for Rs 133-cr railway project
  03-Jul-24   15:38
  Cholamandalam Financial Holdings Ltd leads losers in 'A' group
  03-Jul-24   15:00
  Sakuma Exports Ltd leads losers in 'B' group
  03-Jul-24   14:45
  NTPC power generation climbs 9.5% YoY in Q1
  03-Jul-24   14:41
  Volumes soar at MMTC Ltd counter
  03-Jul-24   14:30
  Oil and Gas shares fall
  03-Jul-24   14:00
  Real Estate stocks edge lower
  03-Jul-24   14:00
  Energy stocks edge lower
  03-Jul-24   14:00
  Sundaram-Clayton gains after board OKs to raise funds upto Rs 400 cr
  03-Jul-24   13:38
  JSW Infra's subsidiary concession agreement V.O. Chidambaranar Port Authority
  03-Jul-24   13:34
Back Top